<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02356783</url>
  </required_header>
  <id_info>
    <org_study_id>#2014-135</org_study_id>
    <nct_id>NCT02356783</nct_id>
  </id_info>
  <brief_title>Implementation of Pedometer for Monitoring Step Count Pre and Post Lumbar ESI for Radicular Pain</brief_title>
  <official_title>Implementation of Wireless Pedometer for Monitoring Step Count Before and After Lumbar Epidural Steroid Injection for Radicular Pain.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital for Special Surgery, New York</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Memorial Sloan Kettering Cancer Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital for Special Surgery, New York</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Our aim is to assess usability and compliance of a wireless pedometer for monitoring step
      count after a lumbar epidural steroid injection for the treatment of radicular pain in low
      back pain patients. Our main hypothesis is to demonstrate pedometer measured step count can
      be used to measure efficacy of pain interventions.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2015</start_date>
  <completion_date type="Actual">September 2016</completion_date>
  <primary_completion_date type="Actual">August 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of Patients With Available Step Count Data at Baseline.</measure>
    <time_frame>A week pre-procedure.</time_frame>
    <description>Percentage of patients with available step count data 7 days pre-procedure. Step count will be obtained daily for 7 days using a wireless pedometer.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of Patients With Available Step Count Data Post-procedure.</measure>
    <time_frame>Duration of 60 days after procedure.</time_frame>
    <description>Percentage of patients with available step count data 60 days post-procedure. Step count will be obtained using a wireless pedometer daily for a period of 60 days post-procedure.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">43</enrollment>
  <condition>Chronic Low Back Pain</condition>
  <arm_group>
    <arm_group_label>Interlaminar</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Approach for lumbar epidural steroid injection for this arm will be interlaminar.
We will be implementing a wireless pedometer to each of the 15 patients in this group to measure our primary and secondary outcomes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Transforaminal</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Approach for lumbar epidural steroid injection for this arm will be transforaminal.
We will be implementing a wireless pedometer to each of the 15 patients in this group to measure our primary and secondary outcomes.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pedometer</intervention_name>
    <description>Wireless pedometer</description>
    <arm_group_label>Interlaminar</arm_group_label>
    <arm_group_label>Transforaminal</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years of age and older

          -  Patients receiving lumbar epidural steroid injections as pain management to be
             scheduled at least one week away (-2 days/1 month).

          -  Patients who are able to understand how the Fitbit instrument works and are willing to
             consent to the study.

          -  Patient who used web-based communication frequently, e.g. Email.

          -  Patients who can speak, understand, and write in English.

          -  Prior MRI or an appointment to obtain an MRI prior to the procedure.

        Exclusion Criteria:

          -  Workers' compensation cases.

          -  Patient does not have a computer at home.

          -  Non-ambulatory patients.

          -  Patients who have received a lumbar epidural steroid injection in the past 6 months.

          -  Nursing or pregnant women.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert Griffin, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital for Special Surgery, New York</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital For Special Surgery</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Cohen, Steven P et al. 2013. &quot;Epidural Steroids: A Comprehensive, Evidence-Based Review.&quot; Regional anesthesia and pain medicine 38(3): 175-200. http://www.ncbi.nlm.nih.gov/pubmed/23598728 (April 2, 2014).</citation>
  </reference>
  <reference>
    <citation>MacVicar J, King W, Landers MH, Bogduk N. The effectiveness of lumbar transforaminal injection of steroids: a comprehensive review with systematic analysis of the published data. Pain Med. 2013 Jan;14(1):14-28. doi: 10.1111/j.1526-4637.2012.01508.x. Epub 2012 Oct 30. Review.</citation>
    <PMID>23110347</PMID>
  </reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 13, 2015</study_first_submitted>
  <study_first_submitted_qc>February 2, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 5, 2015</study_first_posted>
  <results_first_submitted>February 5, 2018</results_first_submitted>
  <results_first_submitted_qc>March 12, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">April 9, 2018</results_first_posted>
  <last_update_submitted>March 12, 2018</last_update_submitted>
  <last_update_submitted_qc>March 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Back Pain</mesh_term>
    <mesh_term>Low Back Pain</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>Forty-three patients were enrolled in study and received FitBit prior to their steroid injection appointment. Only 33 patients returned to have the steroid injection (16 interlaminar, 17 transforaminal). Three transforaminal and 1 interlaminar patient stopped using/syncing the FitBit, so data were not available to analyze.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Interlaminar</title>
          <description>Approach for lumbar epidural steroid injection for this arm will be interlaminar.
We will be implementing a wireless pedometer to each of the 15 patients in this group to measure our primary and secondary outcomes.
Pedometer: Wireless pedometer</description>
        </group>
        <group group_id="P2">
          <title>Transforaminal</title>
          <description>Approach for lumbar epidural steroid injection for this arm will be transforaminal.
We will be implementing a wireless pedometer to each of the 15 patients in this group to measure our primary and secondary outcomes.
Pedometer: Wireless pedometer</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
                <participants group_id="P2" count="17"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="14"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Interlaminar</title>
          <description>Approach for lumbar epidural steroid injection for this arm will be interlaminar.
We will be implementing a wireless pedometer to each of the 15 patients in this group to measure our primary and secondary outcomes.
Pedometer: Wireless pedometer</description>
        </group>
        <group group_id="B2">
          <title>Transforaminal</title>
          <description>Approach for lumbar epidural steroid injection for this arm will be transforaminal.
We will be implementing a wireless pedometer to each of the 15 patients in this group to measure our primary and secondary outcomes.
Pedometer: Wireless pedometer</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="15"/>
            <count group_id="B2" value="14"/>
            <count group_id="B3" value="29"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="54.9" spread="16.2"/>
                    <measurement group_id="B2" value="51.5" spread="12.9"/>
                    <measurement group_id="B3" value="53.3" spread="14.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>count of participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Patients With Available Step Count Data at Baseline.</title>
        <description>Percentage of patients with available step count data 7 days pre-procedure. Step count will be obtained daily for 7 days using a wireless pedometer.</description>
        <time_frame>A week pre-procedure.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Interlaminar</title>
            <description>Approach for lumbar epidural steroid injection for this arm will be interlaminar.
We will be implementing a wireless pedometer to each of the 15 patients in this group to measure our primary and secondary outcomes.
Pedometer: Wireless pedometer</description>
          </group>
          <group group_id="O2">
            <title>Transforaminal</title>
            <description>Approach for lumbar epidural steroid injection for this arm will be transforaminal.
We will be implementing a wireless pedometer to each of the 15 patients in this group to measure our primary and secondary outcomes.
Pedometer: Wireless pedometer</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Patients With Available Step Count Data at Baseline.</title>
          <description>Percentage of patients with available step count data 7 days pre-procedure. Step count will be obtained daily for 7 days using a wireless pedometer.</description>
          <units>percentage of patients with step data</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93.3"/>
                    <measurement group_id="O2" value="71.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Patients With Available Step Count Data Post-procedure.</title>
        <description>Percentage of patients with available step count data 60 days post-procedure. Step count will be obtained using a wireless pedometer daily for a period of 60 days post-procedure.</description>
        <time_frame>Duration of 60 days after procedure.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Interlaminar</title>
            <description>Approach for lumbar epidural steroid injection for this arm will be interlaminar.
We will be implementing a wireless pedometer to each of the 15 patients in this group to measure our primary and secondary outcomes.
Pedometer: Wireless pedometer</description>
          </group>
          <group group_id="O2">
            <title>Transforaminal</title>
            <description>Approach for lumbar epidural steroid injection for this arm will be transforaminal.
We will be implementing a wireless pedometer to each of the 15 patients in this group to measure our primary and secondary outcomes.
Pedometer: Wireless pedometer</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Patients With Available Step Count Data Post-procedure.</title>
          <description>Percentage of patients with available step count data 60 days post-procedure. Step count will be obtained using a wireless pedometer daily for a period of 60 days post-procedure.</description>
          <units>percentage of patients with step data</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="73.3"/>
                    <measurement group_id="O2" value="57.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Interlaminar</title>
          <description>Approach for lumbar epidural steroid injection for this arm will be interlaminar.
We will be implementing a wireless pedometer to each of the 15 patients in this group to measure our primary and secondary outcomes.
Pedometer: Wireless pedometer</description>
        </group>
        <group group_id="E2">
          <title>Transforaminal</title>
          <description>Approach for lumbar epidural steroid injection for this arm will be transforaminal.
We will be implementing a wireless pedometer to each of the 15 patients in this group to measure our primary and secondary outcomes.
Pedometer: Wireless pedometer</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Robert Griffin, MD, PhD</name_or_title>
      <organization>Hospital for Special Surgery</organization>
      <phone>212-774-2944</phone>
      <email>griffinr@hss.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

